Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Rhoshan Pharmaceuticals.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Rhoshan Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Chadds Ford, Pennsylvania
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the terms of the agreement, Hyloris acquires the worldwide license to all intellectual property rights, and technical proprietary information in relation to the IV formulation technology to develop intravenous acetylsalicylic acid (HY-073) in multiple indications.


Lead Product(s): Aspirin

Therapeutic Area: Cardiology/Vascular Diseases Product Name: HY-073

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Hyloris Pharmaceuticals

Deal Size: $7.5 million Upfront Cash: $0.7 million

Deal Type: Licensing Agreement October 13, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY